Abstract
Mouse hematopoietic stem cells (HSCs) first emerge at embryonic day 10.5 (E10.5) on the ventral surface of the dorsal aorta through a process known as endothelial-to-hematopoietic transition (EHT). This study investigates the role of mesenchymal stem cell-like stromal cells in the aorta-gonad-mesonephros (AGM) region and their contribution to EHT. Using lineage tracing, we demonstrate that the early aortic endothelium and HSCs are supported by mesoderm-derived ($Mesp1^{der}$) PDGFRA<sup>+</sup> stromal cells (PSCs). These cells dominate the AGM stroma during the peak of HSC emergence but are replaced by neural crest-derived ($Wnt1^{der}$) PSCs by E13.5, coinciding with the cessation of local hematopoiesis. Crucially, co-aggregating non-hemogenic endothelial cells with $Mesp1^{der}$ PSCs—but not $Wnt1^{der}$ PSCs—reprograms the endothelium to undergo EHT and generate functional long-term HSCs (LT-HSCs). This process is dependent on PDGFRA, BMP, WNT, and NOTCH signaling, offering a potential blueprint for the ex vivo manufacture of LT-HSCs.
Introduction
Hematopoietic stem cells (HSCs) are the foundation of the blood system, possessing the unique ability to self-renew and differentiate into all blood lineages. While HSCs are widely used in clinical bone marrow transplants, the ability to generate them de novo from pluripotent or endothelial sources remains a significant challenge in regenerative medicine.
In nature, HSCs emerge during a brief embryonic window via Endothelial-to-Hematopoietic Transition (EHT), where specialized endothelial cells in the dorsal aorta transform into hematopoietic clusters. This study explores the hypothesis that the surrounding microenvironment, or "niche," provides the essential signals required for this transition. Specifically, the researchers focused on the role of PDGFRA<sup>+</sup> stromal cells (PSCs) within the aorta-gonad-mesonephros (AGM) region.
The Developmental Dynamics of the Aortic Niche
Using sophisticated lineage-tracing models ($Mesp1$-cre and $Wnt1$-cre), the researchers mapped the origins of the stromal cells surrounding the dorsal aorta. They discovered a dramatic population shift that explains why the aorta’s blood-making capacity is temporary:
- The Mesoderm Phase (E10.5–E11.5): During the peak of HSC production, the sub-endothelial and ventral stroma are dominated by mesoderm-derived ($Mesp1^{der}$) PSCs. These cells are concentrated on the ventral side of the aorta, precisely where EHT occurs.
- The Neural Crest Phase (E13.5): By E13.5, the $Mesp1^{der}$ cells are largely replaced by neural crest-derived ($Wnt1^{der}$) PSCs. This shift correlates with the loss of the aorta's ability to generate new HSCs.
Reprogramming the Endothelium
The most striking finding of the study was the functional potency of $Mesp1^{der}$ PSCs. In co-aggregation cultures, these cells were able to induce a hematopoietic transcriptional program in "non-hemogenic" endothelial cells—vessel cells that do not normally produce blood.
Remarkably, this reprogramming was successful even when using endothelial cells from adult tissues, such as the heart or the inferior vena cava. When these reprogrammed cells were transplanted into irradiated mice, they successfully reconstituted the entire blood system for over six months, proving they had become true long-term HSCs (LT-HSCs). In contrast, the later-appearing $Wnt1^{der}$ PSCs lacked this inductive capability, highlighting a functional divergence based on developmental origin.
Molecular Mechanisms of Induction
The study identified a complex signaling interplay between the endothelium and the stroma. The process is initiated by a "handshake" involving the ligand PDGF-AA (produced by the endothelium) and the receptor PDGFRA (expressed on the $Mesp1^{der}$ stroma).
Activation of the stromal cells triggers the release of a specific cocktail of morphogens, including BMP, WNT, and NOTCH signals. The researchers demonstrated that dose-dependent inhibition of any of these pathways—or the deletion of PDGFRA<sup>+</sup> cells entirely—interrupted the reprogramming event and prevented the emergence of HSCs. This suggests that the $Mesp1^{der}$ niche acts as a signal integrator that orchestrates the EHT process.
Discussion and Future Directions
This research identifies $Mesp1^{der}$ PSCs as the "secret sauce" of the embryonic AGM, capable of unlocking the hematopoietic potential of ordinary endothelial cells. The discovery that adult cells can be reverted to a hemogenic state using these niche cells provides a promising roadmap for manufacturing blood stem cells in the lab.
However, several challenges remain. As the study was conducted in mouse models, the human equivalent of these $Mesp1^{der}$ niche cells must be identified. Furthermore, while the study identified the broad signaling pathways involved, the precise molecular recipe required to replace live stromal cells with a defined, synthetic medium is still under investigation. Refining this "niche-mimetic" cocktail will be essential for translating these findings into clinical therapies for patients requiring bone marrow transplantation.
Summary updated